Doctors at AdventHealth said they’ve seen a rise in COVID-19 patients in the last week. They also said the patients have been younger, in their 30s and 40s.
While they have the capacity to treat them, they say it can be difficult deciding which treatment to use.“It’s not like Russian roulette when you just say ‘let me pick this drug, let me pick that drug’ we use science and prior evidence of successful treatment and apply it to COVID,” said Dr.
Eduardo Oliveira, the Chief of Critical Care at AdventHealth.The FDA recently revoked the emergency use authorization of hydroxychloroquine, saying the drug showed no benefit for treating the virus.Now there’s a new drug in the spotlight, Dexamethasone.